P15: EVOLUTION OF MULTIPLE MYELOMA TREATMENT PATTERNS FROM 2015 THROUGH 2019: REAL-WORLD EVIDENCE FROM A EUROPEAN DATABASE STUDY
Main Authors: | A Oriol Rocafiguera, T H Steinmetz, A Brescianini, S Gonzalez-McQuire, N Eugene, A Abbasi, S Wetten, X Leleu |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-04-01
|
Series: | HemaSphere |
Online Access: | http://journals.lww.com/10.1097/01.HS9.0000829632.52535.d2 |
Similar Items
-
P24: EXPERT PERSPECTIVES OF UNMET NEED IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) WHO RECEIVE LENALIDOMIDE-SPARING REGIMENS IN EUROPE
by: M Mateos, et al.
Published: (2022-04-01) -
A casa estranhada
by: Scott McQuire
Published: (2011-10-01) -
Real‐world use of carfilzomib combined with lenalidomide and dexamethasone in patients with multiple myeloma in Europe and Israel
by: Xavier Leleu, et al.
Published: (2023-02-01) -
Real-World Use and Effectiveness of Carfilzomib Plus Dexamethasone in Relapsed/Refractory Multiple Myeloma in Europe
by: Evangelos Terpos, et al.
Published: (2022-10-01) -
Decision and organization : a volume in honor of Jacob Marschak /
by: Marschak, Jacob, et al.
Published: (1972)